NCT06598436 Achieving Chronic Care equiTy by leVeraging the Telehealth Ecosystem
| NCT ID | NCT06598436 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 600 participants |
| Start Date | 2024-11-04 |
| Primary Completion | 2028-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 600 participants in total. It began in 2024-11-04 with a primary completion date of 2028-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study examines the impact of a multi-level intervention aiming to improve telehealth access for low-income patients managing chronic health conditions, such as hypertension and diabetes. The multi-level intervention includes clinic-level practice facilitation and patient-level digital health coaching.
Eligibility Criteria
Inclusion Criteria: * ≥ 18 years of age * English or Spanish-Speaking * Have uncontrolled diabetes defined as a listed diagnosis of diabetes with a recorded A1C ≥ 8.0% in the past two years or have uncontrolled HTN defined as a listed diagnosis of HTN and last recorded documented SBP \>140 mmHg * At least 2 visits at a participating SFHN primary care site in the last 24 months Exclusion Criteria: * Higher than average digital literacy, defined as an Digital Healthcare Literacy Scale (DHLS) score greater than 10, as determined prior to the baseline study visit; these patients may not benefit from a digital coaching intervention. * Presence of co-morbid conditions that would make it inappropriate to focus on telehealth chronic disease management. Conditions may include: end-stage or terminal condition with limited life expectancy and severe mental illness. * Lack of any working phone number * Visual or hearing impairment that precludes use of telehealth for chronic disease management * Cognitive impairment defined by the inability to restate study goals during the consent process * Pregnant
Contact & Investigator
Delphine Tuot, MD MAS
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT06598436 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06598436 currently recruiting?
Yes, NCT06598436 is actively recruiting participants. Contact the research team at Andy.Ramirez@ucsf.edu for enrollment information.
Where is the NCT06598436 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT06598436 clinical trial?
NCT06598436 is sponsored by University of California, San Francisco. The principal investigator is Delphine Tuot, MD MAS at University of California, San Francisco. The trial plans to enroll 600 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.